Market Price

154.00 

-1.00 -0.7%

as of Oct 16 '19

52 Week Range:

87.60 178.00


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Sartorius Aktiengesellschaft supplies pharmaceutical and laboratory equipment worldwide. It operates in two divisions, Bioprocess Solutions, and Lab Products & Services. The company offers products for suspension cell analysis and live-cell analysis inside incubator for oncology, immuno-oncology, antibody discovery, neuroscience, and stem cell research; cell culture media, including antibody and recombinant protein, viral vaccines, and regenerative medicine media, as well as general media and downstream buffers; and multi-parallel, single-use, benchtop, stainless steel, microbial, and cell culture bioreactors, as well as cell culture expansion systems and software applications for bioreactors. It also provides lab filtration and purification devices; sterile and virus filtration, crossflow filtration, harvesting, prefiltration, membrane chromatography, air/gas filtration, and integrity testing devices; and liquid storage and shipping, freeze and thaw, mixing, proven integrity, transferring and sampling, connecting and disconnecting, and final filling management products. In addition, the company offers process control and data analytics products, such as process analyzers, automation modules, and data analytics and chemometrics; and microbiology products, and lab water purification systems. Further, it provides lab balances, mass comparators and metrology, moisture analyzers, specialty weighing solutions, weighing accessories, weights/weight sets, paint mixing solutions, and OEM weigh cells; and OEM membrane and device, pipetting and dispensing, and connectivity solutions. Additionally, the company offers bioprocess development engineering, protein expression system, media and process, testing, instrument, and validation services. It serves the life science research, biopharmaceutical manufacturing, quality control and testing, food and beverage, environmental, and paint mixing industries. The company was founded in 1870 and is headquartered in Göttingen, Germany.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Equity (BVPS) 4.27
4.25
3.91
4.32
4.84
5.21
5.72
7.34
7.96
8.72
9.94
growth rate -0.5% -8.0% 10.5% 12.0% 7.6% 9.8% 28.3% 8.5% 9.6% 14.0%
Earnings BIT 26.85
10.27
15.73
79.05
96.49
114.36
128.45
210.41
246.43
261.88
299.50
growth rate -61.8% 53.2% 402.5% 22.1% 18.5% 12.3% 63.8% 17.1% 6.3% 14.4%
Avg.PE 6.93
36.10
17.30
6.33
23.04
13.83
44.18
101.42
38.17
62.87
69.13
growth rate 420.9% -52.1% -63.4% 264.0% -40.0% 219.5% 129.6% -62.4% 64.7% 10.0%
ROA 1.50
-0.87
3.81
4.69
4.77
4.67
3.97
9.32
6.45
5.66
5.86
growth rate -100.0% 100.0% 23.1% 1.7% -2.1% -15.0% 134.8% -30.8% -12.3% 3.5%
ROE 4.25
-2.60
11.29
14.23
15.14
14.95
12.68
27.59
18.76
19.16
20.81
growth rate -100.0% 100.0% 26.0% 6.4% -1.3% -15.2% 117.6% -32.0% 2.1% 8.6%
ROIC 9.19
0.76
6.96
9.61
8.77
8.38
7.36
15.55
10.73
9.34
9.14
growth rate -91.7% 815.8% 38.1% -8.7% -4.5% -12.2% 111.3% -31.0% -13.0% -2.1%
Cur. Ratio 1.07
1.49
1.22
1.21
1.12
1.69
1.75
1.76
1.61
1.71
1.57
growth rate 39.3% -18.1% -0.8% -7.4% 50.9% 3.6% 0.6% -8.5% 6.2% -8.2%
Quick Ratio 0.58
0.90
0.68
0.66
0.56
0.93
0.77
0.95
0.87
0.92
0.79
growth rate 55.2% -24.4% -2.9% -15.2% 66.1% -17.2% 23.4% -8.4% 5.8% -14.1%
Leverage 2.99
3.01
2.91
3.14
3.21
3.19
3.20
2.77
3.02
3.72
3.41
growth rate 0.7% -3.3% 7.9% 2.2% -0.6% 0.3% -13.4% 9.0% 23.2% -8.3%
Balance Sheet Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Acct.Receivable 125.07
82.99
101.00
116.00
126.00
153.00
151.41
208.56
267.46
312.39
326.45
growth rate -33.7% 21.7% 14.9% 8.6% 21.4% -1.0% 37.7% 28.2% 16.8% 4.5%
Acct.Payable 48.00
58.00
47.00
67.07
56.63
70.95
76.37
91.69
120.47
growth rate 20.8% -19.0% 42.7% -15.6% 25.3% 7.6% 20.1% 31.4%
Cur.Assets 271.66
232.96
222.00
278.00
315.00
368.25
436.09
477.38
587.62
672.03
753.95
growth rate -14.3% -4.7% 25.2% 13.3% 16.9% 18.4% 9.5% 23.1% 14.4% 12.2%
Total Assets 865.00
445.60
808.00
960.00
1,071.00
1,181.32
1,273.03
1,437.24
1,752.99
2,297.72
2,526.88
growth rate -48.5% 81.3% 18.8% 11.6% 10.3% 7.8% 12.9% 22.0% 31.1% 10.0%
Cash 21.90
0.30
28.00
41.00
40.00
51.88
40.56
52.80
62.03
59.42
45.16
growth rate -98.6% 9,233.3% 46.4% -2.4% 29.7% -21.8% 30.2% 17.5% -4.2% -24.0%
Inventory 95.62
69.60
77.00
103.00
126.00
138.96
145.94
189.78
222.18
246.12
321.70
growth rate -27.2% 10.6% 33.8% 22.3% 10.3% 5.0% 30.0% 17.1% 10.8% 30.7%
Cur.Liabilities 254.98
156.86
183.00
231.00
281.00
221.91
248.90
270.95
364.37
393.67
480.70
growth rate -38.5% 16.7% 26.2% 21.7% -21.0% 12.2% 8.9% 34.5% 8.0% 22.1%
Liabilities 531.60
277.10
481.00
594.00
666.00
731.07
775.37
792.48
1,016.18
1,491.16
1,553.49
growth rate -47.9% 73.6% 23.5% 12.1% 9.8% 6.1% 2.2% 28.2% 46.7% 4.2%
LT Debt 192.70
0.00
207.00
269.00
242.00
356.28
359.88
346.79
433.03
869.83
878.54
growth rate -100.0% 30.0% -10.0% 47.2% 1.0% -3.6% 24.9% 100.9% 1.0%
Equity 333.40
168.50
327.20
366.10
404.40
367.63
397.92
517.73
579.67
617.79
740.57
growth rate -49.5% 94.2% 11.9% 10.5% -9.1% 8.2% 30.1% 12.0% 6.6% 19.9%
Common Shares 68.00
68.00
68.00
68.00
68.00
68.00
68.00
68.00
68.00
68.00
68.00
growth rate 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Capital Expenditures 22.30
1.60
16.00
39.00
63.00
56.01
86.14
111.44
148.76
197.10
233.18
growth rate -92.8% 900.0% 143.8% 61.5% -11.1% 53.8% 29.4% 33.5% 32.5% 18.3%
Cash Dividends 11.40
7.00
9.30
10.40
13.80
16.20
17.22
18.24
25.82
31.12
34.54
growth rate -38.6% 32.9% 11.8% 32.7% 17.4% 6.3% 5.9% 41.5% 20.5% 11.0%
Cash From OA 53.00
26.00
96.00
79.00
53.00
103.26
129.69
125.36
170.42
206.51
244.52
growth rate -50.9% 269.2% -17.7% -32.9% 94.8% 25.6% -3.3% 35.9% 21.2% 18.4%
FCF per Share -0.16
0.28
1.12
0.59
0.03
0.42
0.40
0.91
-0.15
-3.41
0.44
growth rate 100.0% 300.0% -47.3% -94.9% 1,300.0% -4.8% 127.5% -100.0% 0.0% 100.0%
FCF 19.00
119.00
72.00
27.00
-10.00
47.00
44.00
14.00
22.00
9.00
11.00
growth rate 526.3% -39.5% -62.5% -100.0% 100.0% -6.4% -68.2% 57.1% -59.1% 22.2%
Income Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Sales 611.60
101.00
659.00
733.00
846.00
791.56
891.17
1,114.75
1,300.30
1,404.57
1,566.03
growth rate -83.5% 552.5% 11.2% 15.4% -6.4% 12.6% 25.1% 16.6% 8.0% 11.5%
Op.Income 50.50
7.20
41.00
53.00
64.00
114.36
128.45
210.41
246.43
261.88
299.50
growth rate -85.7% 469.4% 29.3% 20.8% 78.7% 12.3% 63.8% 17.1% 6.3% 14.4%
IBT 26.80
2.30
62.70
79.00
93.90
95.40
96.23
172.38
204.11
201.19
270.69
growth rate -91.4% 2,626.1% 26.0% 18.9% 1.6% 0.9% 79.1% 18.4% -1.4% 34.6%
Net Income 16.30
2.30
41.00
53.00
64.00
52.42
48.49
126.30
102.93
114.73
141.34
growth rate -85.9% 1,682.6% 29.3% 20.8% -18.1% -7.5% 160.5% -18.5% 11.5% 23.2%
EPS 0.18
-0.11
0.46
0.61
0.71
0.77
0.71
1.85
1.50
1.67
2.06
growth rate -100.0% 100.0% 32.6% 16.4% 8.5% -7.8% 160.6% -18.9% 11.3% 23.4%
Gross Profit 286.40
64.20
316.00
357.00
416.00
384.60
422.76
551.75
631.80
706.84
803.60
growth rate -77.6% 392.2% 13.0% 16.5% -7.6% 9.9% 30.5% 14.5% 11.9% 13.7%
R&D 43.90
42.60
44.30
49.00
47.71
43.56
52.51
59.42
68.78
78.20
growth rate -1.5% 4.0% 10.6% -2.6% -8.7% 20.6% 13.2% 15.8% 13.7%

Quarterly Statements

Item Name Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Earnings BIT 67.60
74.00
83.20
84.60
87.00
growth rate 9.5% 12.4% 1.7% 2.8%
Balance Sheet Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Acct.Receivable 336.60
337.90
326.45
342.10
344.00
growth rate 0.4% -3.4% 4.8% 0.6%
Acct.Payable 167.80
172.40
120.47
192.90
200.60
growth rate 2.7% -30.1% 60.1% 4.0%
Cur.Assets 740.80
811.20
753.95
800.20
834.00
growth rate 9.5% -7.1% 6.1% 4.2%
Total Assets 2,418.60
2,515.00
2,526.88
2,659.10
2,716.60
growth rate 4.0% 0.5% 5.2% 2.2%
Cash 51.20
87.20
45.16
50.00
53.80
growth rate 70.3% -48.2% 10.7% 7.6%
Inventory 282.30
310.20
321.70
347.60
369.80
growth rate 9.9% 3.7% 8.1% 6.4%
Cur.Liabilities 456.80
498.30
480.70
585.00
544.90
growth rate 9.1% -3.5% 21.7% -6.9%
Liabilities 1,573.40
1,620.70
1,553.49
1,680.10
1,696.30
growth rate 3.0% -4.2% 8.2% 1.0%
LT Debt 894.00
897.20
878.54
863.30
916.50
growth rate 0.4% -2.1% -1.7% 6.2%
Equity 644.40
679.90
740.57
742.90
771.50
growth rate 5.5% 8.9% 0.3% 3.9%
Common Shares 68.40
68.40
68.39
68.40
68.40
growth rate 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Capital Expenditures 58.50
54.40
79.78
56.10
58.60
growth rate -7.0% 46.7% -29.7% 4.5%
Cash Dividends 34.50
0.04
0.04
42.10
42.10
growth rate -99.9% 0.0% 116,844.4% 0.0%
Cash From OA 53.10
69.70
82.82
105.90
59.20
growth rate 31.3% 18.8% 27.9% -44.1%
FCF -5.40
15.30
3.04
49.80
0.60
growth rate 100.0% -80.1% 1,538.2% -98.8%
Income Statement Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Sales 393.50
395.30
412.33
435.70
459.00
growth rate 0.5% 4.3% 5.7% 5.4%
Op.Income 67.60
74.00
83.20
84.60
87.00
growth rate 9.5% 12.4% 1.7% 2.8%
IBT 60.70
64.90
93.39
72.20
84.40
growth rate 6.9% 43.9% -22.7% 16.9%
Net Income 30.70
34.10
49.94
37.80
44.50
growth rate 11.1% 46.5% -24.3% 17.7%
EPS
growth rate
Gross Profit 201.50
206.60
207.10
223.10
236.10
growth rate 2.5% 0.2% 7.7% 5.8%
R&D 19.50
20.60
16.40
22.60
22.70
growth rate 5.6% -20.4% 37.8% 0.4%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

B (71.15)

YOY Growth Grade:

D (47.87)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 69.18 74.50 55.21
EPS / Growth 2.07

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 13.6%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 13.6% 13.6% 13.6%
Future PE 27.12 50.50 50.50
Future EPS 7.37 7.37 7.37
Value Price
MOS %
49.42
-67.9%
92.03
-40.2%
92.03
-40.2%
MOS Price 24.71 46.02 46.02
IRT 18.02 18.02 18.02

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.